SAB Biotherapeutics (SABS) Interest & Investment Income: 2021-2025
Historic Interest & Investment Income for SAB Biotherapeutics (SABS) over the last 5 years, with Sep 2025 value amounting to $655,233.
- SAB Biotherapeutics' Interest & Investment Income rose 136.40% to $655,233 in Q3 2025 from the same period last year, while for Sep 2025 it was $867,667, marking a year-over-year decrease of 46.89%. This contributed to the annual value of $1.3 million for FY2024, which is 119.84% up from last year.
- According to the latest figures from Q3 2025, SAB Biotherapeutics' Interest & Investment Income is $655,233, which was up 4,731.39% from $13,562 recorded in Q2 2025.
- SAB Biotherapeutics' Interest & Investment Income's 5-year high stood at $655,233 during Q3 2025, with a 5-year trough of $3,769 in Q3 2021.
- Over the past 3 years, SAB Biotherapeutics' median Interest & Investment Income value was $136,374 (recorded in 2024), while the average stood at $236,569.
- In the last 5 years, SAB Biotherapeutics' Interest & Investment Income soared by 1,829.64% in 2024 and then plummeted by 96.38% in 2025.
- Over the past 5 years, SAB Biotherapeutics' Interest & Investment Income (Quarterly) stood at $8,544 in 2021, then spiked by 250.29% to $29,929 in 2022, then soared by 1,517.31% to $484,046 in 2023, then plummeted by 71.83% to $136,374 in 2024, then spiked by 136.40% to $655,233 in 2025.
- Its last three reported values are $655,233 in Q3 2025, $13,562 for Q2 2025, and $62,498 during Q1 2025.